Ask Our Doctors – Archive

Our Medical Directors are outstanding physicians that you will find to be very personable and compassionate, who take care to ensure that you have the most cutting-edge fertility treatments at your disposal. This is your outlet to ask your questions to the doctors.

19,771 Comments

  1. Dr My LMP was August 23rd,2020. And my HCG level on Oct 1,2020 is 2209… So is this level good for a normal pregnancy…

    • It is promising!

      Good luck!

      Geoff Sher

  2. Hi dr Sher,
    Which should I transfer first?
    I have two PGS tested normal embryos both are hatching blastocyst Grade A. One is a 5day and one is a 6day blastocyst. Unfortunately the 5day one has been re-frozen as it was accidentally thawed.
    Thanks for your advice

    • I would transfer the day-6 first.

      Geoff Sher

  3. Hello, my name is Cristina and I want to have an operation to release the fallopian tubes to conceive a child. I mention that I have two cesarean births and the last birth was 19 years ago. You can recommend me a private hospital. I live in Burnley

    • Sorry Cristina…I have no idea!

      Good luck!

      Geoff Sher

  4. I started my transfer protocol but it was cancelled because I ovulated around the protocol. This was my protocol. I wasn’t on BC. I started Estradiol patches on Day 4 of my cycle (Started with 2 patches). Changed patches on Cycle Day 6 (3 patches and continued to change every 3 days) The uterine lining check and P4 blood test was done on cycle Day 16. The progesterone level was 4 and Uterine lining was 10mm. The cycle was cancelled because of the P4 level. Do you have any suggestions of what can be done differently to avoid spontaneous ovulation next time? My doctor suggested being on BC for a couple of weeks prior to starting the estrogen patches. Will this help? Thank you so much.

    • Premature ovulation occurs when a premature LH surge occurs prior to the “trigger”. It is an end point of what is often referred to as premature luteinization which also results in so called “empty follicle syndrome”.

      Premature luteinization (“premature LH surge”) occurs when prior to the planned initiation of the hCG trigger, a progressive rise in LH, irreversibly compromises follicle and egg development and maturation. It is not a sporadic isolated event. It comes as a culmination of a series ovarian events, occurring mostly in susceptible women (i.e. usually older women and those with diminished ovarian reserve. It is more likely to occur when the protocol used for ovarian stimulation has failed to maintain LH activity at a low level prior to and throughout the ovarian stimulation process. Once it occurs in any given stimulation cycle it cannot be switched off by changing the stimulation in progress or by administering GnRH antagonists (e.g. Ganirelix/Cetrotide/Orgalutron) midway in the cycle in the hope that this could rescue the eggs under development. It is my opinion, once premature luteinization commences, the cycle is doomed and outcome is doomed to fail. The condition increases the likelihood of premature ovulation, failed release of eggs during needle-guided egg retrieval (so called “empty follicle syndrome” and the incidence of egg/embryo “incompetence” (chromosomal aneuploidy).
      This situation is most commonly seen in older women and in women who have severely diminished ovarian reserve. In many cases its effect can be prevented through implementation of strategic and individualized protocols for controlled ovarian stimulation (COS) coupled with optimizing the type, timing and dosage of the “hCG trigger shot.”
      Normally, following optimal ovarian stimulation, the “trigger shot” is given for the purpose of it initiating meiosis (reproductive division) that is intended to halve the number of chromosomes from 46 to 23 within 32-36 hours. The hCG trigger also enables the egg to signal the “cumulus cells” that bind it firmly to the inner wall of the follicle (through enzymatic activity), to loosen or disperse, so that the egg can detach and readily be captured at egg retrieval (ER).
      Older women, and women with diminished ovarian reserve, tend to have more biologically active LH in circulation. LH causes production of male hormone (androgens, predominantly testosterone), by ovarian connective tissue (stroma/theca). A little testosterone is needed for optimal follicle development and for FSH-induced ovogenesis (egg development). Too much LH activity compromises the latter, and eggs so affected are far more likely to be aneuploid following meiosis.
      Women with the above mentioned conditions often have increased LH activity and are thus more likely to produce excessive ovarian testosterone. It follows that sustained, premature elevations in LH or premature luteinization (often referred to as a “premature LH surge”) will prejudice egg development. Such compromised eggs are much more likely to end up being complex aneuploid following the administration of the hCG trigger, leading to fruitless attempts at retrieval and the so called “empty follicle syndrome.”
      The developing eggs of women who have increased LH activity (older women, and women with diminished ovarian reserve) are inordinately vulnerable to the effects of protracted exposure to LH-induced ovarian testosterone. Because of this, the administration of medications that provoke further pituitary LH release (e.g., clomiphene and Letrozole), drugs that contain LH or hCG (e.g., Menopur), or protocols of ovarian stimulation that provoke increased exposure to the woman’s own pituitary LH (e.g., “flare-agonist protocols”) and the use of “late pituitary blockade” (antagonist) protocols can be prejudicial.
      The importance of individualizing COS protocol selection, precision with regard to the dosage and type of hCG trigger used, and the timing of its administration in such cases cannot be overstated. The ideal dosage of urinary-derived hCG (hCG-u) such as Novarel, Pregnyl and Profasi is 10,000U. When recombinant DNA-derived hCG (hCG-r) such as Ovidrel is used, the optimal dosage is 500mcg. A lower dosage of hCG or Ovidrel can, by compromising meiosis, increase the risk of egg aneuploidy, and thus of IVF outcome.

      I strongly recommend that you visit http://www.DrGeoffreySherIVF.com. Then go to my Blog and access the “search bar”. Type in the titles of any/all of the articles listed below, one by one. “Click” and you will immediately be taken to those you select. Please also take the time to post any questions or comments with the full expectation that I will (as always) respond promptly.
      •Implications of “Empty Follicle Syndrome and “Premature Luteinization”
      •Premature Luteinization (“the premature LH surge): Why it happens and how it can be prevented.
      •Fertility Preservation (FP) Through Freezing/Banking Human Eggs
      •The IVF Journey: The importance of “Planning the Trip” Before Taking the Ride”
      •Controlled Ovarian Stimulation (COS) for IVF: Selecting the ideal protocol
      •IVF: Factors Affecting Egg/Embryo “competency” during Controlled Ovarian Stimulation(COS)
      •The Fundamental Requirements For Achieving Optimal IVF Success
      •Use of GnRH Antagonists (Ganirelix/Cetrotide/Orgalutron) in IVF-Ovarian Stimulation Protocols.
      •Anti Mullerian Hormone (AMH) Measurement to Assess Ovarian Reserve and Design the Optimal Protocol for Controlled Ovarian Stimulation (COS) in IVF.
      •The “Biological Clock” and how it should Influence the Selection and Design of Ovarian Stimulation Protocols for IVF.
      • A Rational Basis for selecting Controlled Ovarian Stimulation (COS) protocols in women with Diminished Ovarian Reserve (DOR)
      •Diagnosing and Treating Infertility due to Diminished Ovarian Reserve (DOR)
      •Ovarian Stimulation in Women Who have Diminished Ovarian Reserve (DOR): Introducing the Agonist/Antagonist Conversion protocol
      •Controlled Ovarian Stimulation (COS) in Older women and Women who have Diminished Ovarian Reserve (DOR): A Rational Basis for Selecting a Stimulation Protocol
      •Optimizing Response to Ovarian Stimulation in Women with Compromised Ovarian Response to Ovarian Stimulation: A Personal Approach.
      •Egg Maturation in IVF: How Egg “Immaturity”, “Post-maturity” and “Dysmaturity” Influence IVF Outcome:
      •Commonly Asked Question in IVF: “Why Did so Few of my Eggs Fertilize and, so Many Fail to Reach Blastocyst?”
      •Human Growth Hormone Administration in IVF: Does it Enhances Egg/Embryo Quality and Outcome?
      •The BCP: Does Launching a Cycle of Controlled Ovarian Stimulation (COS). Coming off the BCP Compromise Response?
      •Staggered IVF with PGS- Selection of “Competent” Embryos Greatly Enhances the Utility & Efficiency of IVF.
      •Staggered IVF: An Excellent Option When. Advancing Age and Diminished Ovarian Reserve (DOR) Reduces IVF Success Rate
      •Embryo Banking/Stockpiling: Slows the “Biological Clock” and offers a Selective Alternative to IVF-Egg Donation
      •Preimplantation Genetic Testing (PGS) in IVF: It should be Used Selectively and NOT be Routine.
      •IVF: Selecting the Best Quality Embryos to Transfer
      •Preimplantation Genetic Sampling (PGS) Using: Next Generation Gene Sequencing (NGS): Method of Choice.
      •PGS in IVF: Are Some Chromosomally abnormal Embryos Capable of Resulting in Normal Babies and Being Wrongly Discarded?
      •PGS and Assessment of Egg/Embryo “competency”: How Method, Timing and Methodology Could Affect Reliability
      •IVF outcome: How Does Advancing Age and Diminished Ovarian Reserve (DOR) Affect Egg/Embryo “Competency” and How Should the Problem be addressed.
      •IVF: The first Choice for Infertile Women 40 to 43 Years of Age!
      •IVF Egg Donation: A Comprehensive Overview

      ______________________________________________________
      ADDENDUM: PLEASE READ!!
      INTRODUCING SHER FERTILITY SOLUTIONS (SFS)
      I launched Sher-Fertility Solutions (SFS) in April 2019. Through SFS, I now provide guidance, through online Skype/FaceTime consultations to people with often complex Reproductive Issues, from > 40. All consultations are followed by a detailed written report presenting my recommendations for treatment. Patients are encouraged to share this with their personal treating doctor(s) and/or to avail themselves of my hands-on IVF services, provided in batched cycles, conducted every 3 months at LAIVF in Century City, Los Angeles, CA.
      If you wish to schedule a 1 hour , online consultation with me, please contact my assistant (Patti Converse) at 1-800-780-7437 or 702-533-2691. Alternatively , email Patti at concierge@SherIVF.com or enroll online at my website, http://www.SherIVF.com..

      PLEASE HELP SPREAD THE WORD ABOUT SFS!

      Geoff Sher

  5. Hello Dr Sher,
    I’m almost 37 years old and just had a retrieval where I had 8 follicles grow, 6 eggs retrieved, 5 mature, 3 fertilize, and 2 blastocysts (Day 6) sent for genetic testing during my first cycle. Is it better to do another another cycle now before any embryo transfer? Should similar retrieval results be expected? How soon can a second cycle be done? How long will it delay an embryo transfer?

    • Banking as many euploid embryos as possible is a good idea. The reason is to to try and “make hay while the sun shines”.

      I would take 1 full resting cycle off before trying again.

      Good luck!

      Geoff Sher